SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 230 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1 | -66.7% | 2,886 | -6.5% | 0.00% | – |
| Q4 2022 | $3 | -100.0% | 3,086 | -77.9% | 0.00% | – |
| Q3 2022 | $22,000 | -21.4% | 13,986 | 0.0% | 0.00% | – |
| Q2 2022 | $28,000 | -89.7% | 13,986 | -88.0% | 0.00% | -100.0% |
| Q1 2022 | $271,000 | +2363.6% | 116,290 | +3534.1% | 0.00% | – |
| Q4 2021 | $11,000 | -99.4% | 3,200 | -98.8% | 0.00% | -100.0% |
| Q3 2021 | $1,972,000 | -21.2% | 258,450 | 0.0% | 0.01% | -25.0% |
| Q2 2021 | $2,504,000 | +3477.1% | 258,450 | +2958.6% | 0.02% | – |
| Q1 2021 | $70,000 | +11.1% | 8,450 | -8.2% | 0.00% | – |
| Q4 2020 | $63,000 | -68.7% | 9,200 | -49.0% | 0.00% | -100.0% |
| Q3 2020 | $201,000 | +1727.3% | 18,050 | +961.8% | 0.00% | – |
| Q2 2020 | $11,000 | +266.7% | 1,700 | -7.6% | 0.00% | – |
| Q1 2020 | $3,000 | – | 1,840 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 15,001 | $1,410 | 0.00% |
| KLCM Advisors, Inc. | 20,000 | $1,880 | 0.00% |
| AlphaMark Advisors, LLC | 3,135 | $0 | 0.00% |
| TRUST CO OF VERMONT | 204 | $19 | 0.00% |
| SlateStone Wealth, LLC | 30,866 | $3 | 0.00% |
| Coppell Advisory Solutions LLC | 100 | $89 | 0.00% |
| Highlander Capital Management, LLC | 1,200 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Russell Investments Group, Ltd. | 266 | $25 | 0.00% |
| OGOREK ANTHONY JOSEPH /NY/ /ADV | 3,600 | $0 | 0.00% |